EUVIMEDEUVIMED entdecken
Crossref

Immunohistochemical Analysis of Ki-67 and CD34 in Benign and Malignant Salivary Gland Tumors

Lipika Behera, Saradbrata Mishra, Anuradha Panda, Atanu Kumar Bal

International Journal of Current Pharmaceutical Review and Research · 30.07.2026 · 18 (07)

DOI: 10.25258/ijcpr.18.7.226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.07.2026. Verfasst von Lipika Behera und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Salivary gland tumors constitute a heterogeneous group of neoplasms with diverse histopathological features, making accurate diagnosis and prognostic assessment challenging. Although histopathology remains the diagnostic gold standard, immunohistochemical markers may improve diagnostic precision and provide insight into tumor biology. Ki-67 is a well-established marker of cellular proliferation, while CD34 is a marker of tumor angiogenesis. This study evaluated the expression of Ki-67 and CD34 in benign and malignant salivary gland tumors and assessed their diagnostic utility.

Methods

A prospective observational study was conducted on 77 histologically confirmed salivary gland tumors received in the Department of Pathology, M.K.C.G. Medical College, Berhampur, over a two-year period (October 2015–September 2017). Routine histopathological examination was performed using hematoxylin and eosin staining, followed by immunohistochemical analysis with Ki-67 and CD34 antibodies. Ki-67 labelling index and CD34-assessed MVD (Micro-Vessel Density) were evaluated and correlated with clinicopathological parameters and tumor type.

Results

Among the 77 tumors, 45 (58.44%) were benign and 32 (41.56%) were malignant. Pleomorphic adenoma was the commonest benign tumor (46.75%), while mucoepidermoid carcinoma was the most frequent malignant tumor (25.97%). Ki-67 positivity was observed in 90.62% of malignant and 31.11% of benign tumors, with significantly higher mean labeling indices in malignant tumors (26.56±16.08 vs. 3.57±3.75). CD34-assessed MVD was also significantly higher in malignant tumors (27.59±12.00) than benign tumors (7.40±6.49). Ki-67 expression correlated with patient age but not with gender, tumor size, or site. CD34 MVD showed a significant association with age but no correlation with Ki-67 labelling index.

Conclusion

Ki-67 and CD34 are valuable adjunctive immunohistochemical markers in salivary gland tumors. Increased Ki-67 expression reflects enhanced proliferative activity, while higher CD34 microvessel density indicates increased angiogenesis in malignant lesions. Their combined assessment can aid in differentiating benign from malignant salivary gland tumors and provide useful information regarding tumor behaviour and prognosis

Zitieren

APA

Behera, L., Mishra, S., Panda, A., & Bal, A. K. (2026). Immunohistochemical Analysis of Ki-67 and CD34 in Benign and Malignant Salivary Gland Tumors. International Journal of Current Pharmaceutical Review and Research, 18(07). https://doi.org/10.25258/ijcpr.18.7.226

Vancouver

Behera L, Mishra S, Panda A, Bal AK. Immunohistochemical Analysis of Ki-67 and CD34 in Benign and Malignant Salivary Gland Tumors. International Journal of Current Pharmaceutical Review and Research. 2026;18(07). doi:10.25258/ijcpr.18.7.226

BibTeX
@article{Behera2026,
  author = {Behera, Lipika and Mishra, Saradbrata and Panda, Anuradha and Bal, Atanu Kumar},
  title = {Immunohistochemical Analysis of Ki-67 and CD34 in Benign and Malignant Salivary Gland Tumors},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {07},
  doi = {10.25258/ijcpr.18.7.226}
}
Kostenlos starten →